Procter & Gamble delivered robust Q2 results, exceeding earnings expectations and raising fiscal year guidance, which reflects strong integration with Gillette and effective cost management. The positive management tone and ongoing strategic initiatives are likely to boost investor confidence, supporting a rise in the stock price over the next couple of weeks.

[1]